Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
Mol Cancer
.
2022 Dec 9;21(1):214.
doi: 10.1186/s12943-022-01692-9.
Authors
Barbara Nuvoli
1
,
Sabrina Germoni
2
,
Carlotta Morosetti
1
,
Raffaela Santoro
1
,
Giancarlo Cortese
2
,
Serena Masi
3
,
Iole Cordone
3
,
Rossella Galati
4
Affiliations
1
Molecular Medicine Area, Regina Elena National Cancer Institute, 00144, Rome, Italy.
2
S.A.F.U. Department, Regina Elena National Cancer Institute, Rome, Italy.
3
Clinical Pathology, Regina Elena National Cancer Institute, Rome, Italy.
4
Molecular Medicine Area, Regina Elena National Cancer Institute, 00144, Rome, Italy. galati@ifo.it.
PMID:
36482446
PMCID:
PMC9733132
DOI:
10.1186/s12943-022-01692-9
No abstract available
Publication types
Retraction of Publication